Literature DB >> 29299729

Barriers and Facilitators of HPV Vaccination in the VFC Program.

Wayne S Fleming1,2, Kristin K Sznajder3, Margaret Nepps4, Sameh W Boktor5,3.   

Abstract

This study determined facilitators and barriers to human papillomavirus (HPV) vaccination perceived by providers of healthcare in the federally funded Pennsylvania Vaccines for Children (PA VFC) program. The cross-sectional study gathered descriptive data through a survey research design. Providers of healthcare were recruited through an email containing a link to an 18-question online survey. The survey was divided into four main sections which assessed the perceived facilitators and barriers to HPV vaccination of PA VFC program-eligibles. Survey respondents represented 65 of 66 Pennsylvania counties covered by the PA VFC Program. The study recruited 772 PA VFC participating healthcare facilities for a response rate of 52%. Ninety eight percent of the responding facilities reported that they offered the HPV vaccine. The most common barriers to vaccine administration were the parental belief that HPV vaccination is associated with sexual activity and parent/patient refusal of the HPV vaccination which together accounted for (44%) of responses. The majority of respondents (75.6%) indicated counseling parents and adolescents on the benefits of HPV vaccination was a very important factor in HPV vaccination uptake. Healthcare provider facility based training (32%) and web-based training for healthcare providers (22%) were the most recommended avenues for HPV training. The most common barrier to HPV vaccination was identified as the parental misconception that HPV vaccination is associated with sexual activity. Providers believed that the best way to increase HPV vaccination is through counseling parents and adolescents on the benefits of HPV vaccination and to correct misconceptions and change attitudes. Providers are desirous of receiving HPV web-based or workplace training.

Entities:  

Keywords:  Adolescents’ vaccine uptake; HPV vaccine; Human papillomavirus; Vaccine for Children Program

Mesh:

Substances:

Year:  2018        PMID: 29299729     DOI: 10.1007/s10900-017-0457-x

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  6 in total

1.  Human papillomavirus vaccination series initiation and completion, 2008-2009.

Authors:  Christina G Dorell; David Yankey; Tammy A Santibanez; Lauri E Markowitz
Journal:  Pediatrics       Date:  2011-10-17       Impact factor: 7.124

2.  Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women.

Authors:  Anna E Strohl; Gricelda Mendoza; Marissa S Ghant; Kenzie A Cameron; Melissa A Simon; Julian C Schink; Erica E Marsh
Journal:  Am J Obstet Gynecol       Date:  2014-06-28       Impact factor: 8.661

Review 3.  Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.

Authors:  Catherine Lindsey Satterwhite; Elizabeth Torrone; Elissa Meites; Eileen F Dunne; Reena Mahajan; M Cheryl Bañez Ocfemia; John Su; Fujie Xu; Hillard Weinstock
Journal:  Sex Transm Dis       Date:  2013-03       Impact factor: 2.830

4.  Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study.

Authors:  Rebecca B Perkins; Susan B Brogly; William G Adams; Karen M Freund
Journal:  J Womens Health (Larchmt)       Date:  2012-08       Impact factor: 2.681

Review 5.  Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.

Authors:  Dawn M Holman; Vicki Benard; Katherine B Roland; Meg Watson; Nicole Liddon; Shannon Stokley
Journal:  JAMA Pediatr       Date:  2014-01       Impact factor: 16.193

6.  Human Papillomavirus Vaccine Initiation among 9-13-Year-Olds in the United States.

Authors:  Kelly L Donahue; Kristin S Hendrix; Lynne A Sturm; Gregory D Zimet
Journal:  Prev Med Rep       Date:  2015
  6 in total
  3 in total

1.  Parental knowledge gaps and barriers for children receiving human papillomavirus vaccine in the Rio Grande Valley of Texas.

Authors:  Melissa Victory; Thuy Quynh N Do; Yong-Fang Kuo; Ana M Rodriguez
Journal:  Hum Vaccin Immunother       Date:  2019-06-26       Impact factor: 3.452

2.  Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers.

Authors:  Irene O Aninye; J Michael Berry-Lawhorn; Paul Blumenthal; Tamika Felder; Naomi Jay; Janette Merrill; Jenna B Messman; Sarah Nielsen; Rebecca Perkins; Tami Rowen; Debbie Saslow; Connie Liu Trimble; Karen Smith-McCune
Journal:  J Womens Health (Larchmt)       Date:  2021-12-06       Impact factor: 2.681

3.  Association between patient characteristics and HPV vaccination recommendation for postpartum patients: A national survey of Obstetrician/Gynecologists.

Authors:  Paige W Lake; Katharine J Head; Shannon M Christy; Andrea L DeMaria; Erika L Thompson; Susan T Vadaparampil; Gregory D Zimet; Monica L Kasting
Journal:  Prev Med Rep       Date:  2022-04-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.